Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer

2011472 citationsJournal Articlehybrid Open Access

Authors

Kellie A. Charles · University of Sydney

Vickie E. Baracos · University of Alberta

Stephen Clarke · Concord Repatriation General Hospital

Abstract

These results have highlighted NLR as a potentially useful clinical biomarker of systemic inflammatory response in predicting clinically meaningful outcomes in two independent cohorts. Results of this study have also confirmed the importance of a chronic systemic inflammatory response influencing clinical outcomes in patients with mCRC.

Topics & Keywords

Inflammatory Biomarkers in Disease Prognosis Cancer, Lipids, and Metabolism Cancer Immunotherapy and Biomarkers

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: British Journal of Cancer

Volume 104, Issue 8, pp. 1288-1295

DOI: 10.1038/bjc.2011.100

Field-Weighted Citation Impact: 16.05